365 related articles for article (PubMed ID: 22114675)
1. Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis.
Moriishi T; Maruyama Z; Fukuyama R; Ito M; Miyazaki T; Kitaura H; Ohnishi H; Furuichi T; Kawai Y; Masuyama R; Komori H; Takada K; Kawaguchi H; Komori T
PLoS One; 2011; 6(11):e27487. PubMed ID: 22114675
[TBL] [Abstract][Full Text] [Related]
2. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
[TBL] [Abstract][Full Text] [Related]
3. Bcl2 deficiency activates FoxO through Akt inactivation and accelerates osteoblast differentiation.
Moriishi T; Kawai Y; Komori H; Rokutanda S; Eguchi Y; Tsujimoto Y; Asahina I; Komori T
PLoS One; 2014; 9(1):e86629. PubMed ID: 24466179
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and Strength.
Moriishi T; Fukuyama R; Miyazaki T; Furuichi T; Ito M; Komori T
J Bone Miner Res; 2016 Jul; 31(7):1366-80. PubMed ID: 26852895
[TBL] [Abstract][Full Text] [Related]
5. Osteoblast menin regulates bone mass in vivo.
Kanazawa I; Canaff L; Abi Rafeh J; Angrula A; Li J; Riddle RC; Boraschi-Diaz I; Komarova SV; Clemens TL; Murshed M; Hendy GN
J Biol Chem; 2015 Feb; 290(7):3910-24. PubMed ID: 25538250
[TBL] [Abstract][Full Text] [Related]
6. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.
Pereira RC; Salusky IB; Bowen RE; Freymiller EG; Wesseling-Perry K
Bone; 2019 Oct; 127():626-634. PubMed ID: 31377240
[TBL] [Abstract][Full Text] [Related]
8.
Moriishi T; Kawai Y; Fukuyama R; Matsuo Y; He YW; Akiyama H; Asahina I; Komori T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139148
[TBL] [Abstract][Full Text] [Related]
9. In situ localization and in vitro expression of osteoblast/osteocyte factor 45 mRNA during bone cell differentiation.
Igarashi M; Kamiya N; Ito K; Takagi M
Histochem J; 2002 May; 34(5):255-63. PubMed ID: 12588003
[TBL] [Abstract][Full Text] [Related]
10. Smad4 controls bone homeostasis through regulation of osteoblast/osteocyte viability.
Moon YJ; Yun CY; Choi H; Ka SO; Kim JR; Park BH; Cho ES
Exp Mol Med; 2016 Sep; 48(9):e256. PubMed ID: 27585718
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
Wiren KM; Toombs AR; Semirale AA; Zhang X
Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
[TBL] [Abstract][Full Text] [Related]
12. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro.
Zhang W; Pantschenko AG; McCarthy MB; Gronowicz G
Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
14. SP7 inhibits osteoblast differentiation at a late stage in mice.
Yoshida CA; Komori H; Maruyama Z; Miyazaki T; Kawasaki K; Furuichi T; Fukuyama R; Mori M; Yamana K; Nakamura K; Liu W; Toyosawa S; Moriishi T; Kawaguchi H; Takada K; Komori T
PLoS One; 2012; 7(3):e32364. PubMed ID: 22396760
[TBL] [Abstract][Full Text] [Related]
15. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis.
Karsdal MA; Larsen L; Engsig MT; Lou H; Ferreras M; Lochter A; Delaissé JM; Foged NT
J Biol Chem; 2002 Nov; 277(46):44061-7. PubMed ID: 12226090
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.
O'Brien CA; Jia D; Plotkin LI; Bellido T; Powers CC; Stewart SA; Manolagas SC; Weinstein RS
Endocrinology; 2004 Apr; 145(4):1835-41. PubMed ID: 14691012
[TBL] [Abstract][Full Text] [Related]
18. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
Weinstein RS; Jilka RL; Almeida M; Roberson PK; Manolagas SC
Endocrinology; 2010 Jun; 151(6):2641-9. PubMed ID: 20410195
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of stress-associated gene
Shiraki M; Xu X; Iovanna JL; Kukita T; Hirata H; Kamohara A; Kubota Y; Miyamoto H; Mawatari M; Kukita A
FASEB J; 2019 Aug; 33(8):8836-8852. PubMed ID: 31067083
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an osteocyte-like cell line, MLO-Y4.
Kato Y; Windle JJ; Koop BA; Mundy GR; Bonewald LF
J Bone Miner Res; 1997 Dec; 12(12):2014-23. PubMed ID: 9421234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
